DanuCare ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  30.4% 19.9% 19.7% 12.9% 4.8%  
Credit score (0-100)  1 5 5 17 45  
Credit rating  C B B BB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,769 2,824 3,684 6,194 12,007  
EBITDA  -532 77.8 234 1,291 5,857  
EBIT  -532 69.8 214 1,263 5,822  
Pre-tax profit (PTP)  -614.7 6.0 120.4 1,106.7 5,777.2  
Net earnings  -480.9 3.5 -30.3 952.6 4,529.0  
Pre-tax profit without non-rec. items  -615 6.0 120 1,107 5,777  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 40.2 102 96.2 164  
Shareholders equity total  -2,036 -2,032 -2,062 -1,110 3,419  
Interest-bearing liabilities  1,523 1,402 1,513 1,264 1,156  
Balance sheet total (assets)  2,118 2,878 4,654 7,750 12,118  

Net Debt  1,523 1,402 1,142 182 -2,484  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,769 2,824 3,684 6,194 12,007  
Gross profit growth  0.0% 59.6% 30.4% 68.2% 93.8%  
Employees  5 5 7 10 11  
Employee growth %  25.0% 0.0% 40.0% 42.9% 10.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,118 2,878 4,654 7,750 12,118  
Balance sheet change%  49.1% 35.9% 61.7% 66.5% 56.4%  
Added value  -532.4 77.8 233.9 1,282.8 5,857.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 32 42 -33 33  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -30.1% 2.5% 5.8% 20.4% 48.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -14.9% 1.5% 3.7% 16.2% 56.0%  
ROI %  -26.8% 3.3% 6.6% 48.2% 201.2%  
ROE %  -27.2% 0.1% -0.8% 15.4% 81.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -49.0% -41.4% -30.7% -12.5% 28.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -286.1% 1,801.1% 488.4% 14.1% -42.4%  
Gearing %  -74.8% -69.0% -73.3% -113.9% 33.8%  
Net interest  0 0 0 0 0  
Financing costs %  4.3% 4.4% 6.5% 11.4% 7.9%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.4 0.8 1.0 1.0 1.3  
Current Ratio  0.5 1.1 1.5 1.4 1.9  
Cash and cash equivalent  0.0 0.0 370.3 1,081.8 3,640.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,917.2 238.0 1,476.8 2,329.8 5,512.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -106 16 33 128 532  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -106 16 33 129 532  
EBIT / employee  -106 14 31 126 529  
Net earnings / employee  -96 1 -4 95 412